Managing Pharma Equipment and Assets Amid Tariff Pressures and Budget Constraints
Pharma manufacturers are facing new challenges driven by rising global tensions and potential U.S. tariffs on pharmaceutical goods, particularly those sourced from China. Companies like Amgen and Biogen have already […]